Metropolitan Life Insurance CO Igm Biosciences, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$8.68 - $17.36 $6,501 - $13,002	749 New	749 $7,000
Q4 2022 Jun 14, 2023	BUY	$15.45 - $26.02 $9,671 - $16,288	626 New	626 $10.6 Million
Q3 2022 Jun 14, 2023	BUY	$15.42 - $27.01 $9,652 - $16,908	626 New	626 $14.2 Million
Q2 2022 Jun 20, 2023	BUY	$13.27 - $25.5 $8,307 - $15,963	626 New	626 $11,000
Q2 2022 Mar 30, 2023	SELL	$13.27 - $25.5 $22,240 - $42,738	-1,676 Reduced 72.81%	626 $11,000
Q2 2022 Aug 11, 2022	BUY	$13.27 - $25.5 $8,307 - $15,963	626 New	626 $11,000
Q1 2022 May 12, 2022	SELL	$13.42 - $29.73 $30,892 - $68,438	-2,302 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$27.59 - $66.39 $63,512 - $152,829	2,302 New	2,302 $67,000
Q3 2021 Jun 21, 2023	BUY	$65.76 - $90.65 $151,379 - $208,676	2,302 New	2,302 $151,000
Q2 2021 Aug 16, 2021	BUY	$57.98 - $96.6 $133,354 - $222,180	2,300 Added 115000.0%	2,302 $192,000
Q1 2021 Jun 26, 2023	BUY	$71.56 - $121.23 $164,731 - $279,071	2,302 New	2,302 $177 Million
Q1 2021 May 14, 2021	SELL	$71.56 - $121.23 $164,588 - $278,829	-2,300 Reduced 99.91%	2 $177,000
Q4 2020 Jun 22, 2023	BUY	$47.41 - $115.03 $109,137 - $264,799	2,302 New	2,302 $203,000
Q3 2020 Jun 26, 2023	BUY	$43.0 - $84.01 $98,986 - $193,391	2,302 New	2,302 $169,000
Q2 2020 Jun 26, 2023	BUY	$51.3 - $75.21 $118,092 - $173,133	2,302 New	2,302 $168,000
Q2 2020 Mar 30, 2023	BUY	$51.3 - $75.21 $29,497 - $43,245	575 Added 33.29%	2,302 $168,000
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $29,497 - $43,245	575 Added 33.29%	2,302 $168,000
Q1 2020 Jul 12, 2023	BUY	$31.51 - $73.75 $54,417 - $127,366	1,727 New	1,727 $96,000
Q1 2020 Mar 30, 2023	BUY	$31.51 - $73.75 $34,692 - $81,198	1,101 Added 175.88%	1,727 $96,000
Q1 2020 May 15, 2020	BUY	$31.51 - $73.75 $54,417 - $127,366	1,727 New	1,727 $97,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

Baker Bros. Advisors LP New York, NY

4.09M
Shares

$26.6 Million
0.72% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.01M
Shares

$26.1 Million
0.01% of portfolio
Siren, L.L.C. New York, NY

3.33M
Shares

$21.7 Million
2.75% of portfolio
Redmile Group, LLC San Francisco, CA

3.07M
Shares

$20 Million
3.32% of portfolio
Goldman Sachs Group Inc New York, NY

1.26M
Shares

$8.2 Million
0.0% of portfolio

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $189M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account